Margaret Dalesandro
Insider
First SEC filing: March 4, 2024 · Latest: March 4, 2024
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 29, 2024 | SKYE | A | 35,000 | · | · | 35,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 6, 2023 | SKYE | A | 14,110 | · | · | 20,001 Direct | +239.52% | Acquired | (price as of 2026-10-02) |
| Aug. 25, 2023 | SKYE | A | 1,472,692 | · | · | 1,472,692 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 5, 2023 | SKYE | A | 250,000 | · | · | 250,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 14, 2021 | SKYE | A | 150,000 | · | · | 400,000 Direct | +60.00% | Acquired | (price as of 2026-10-02) |
| Aug. 7, 2020 | SKYE | A | 250,000 | · | · | 250,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 29, 2024 | SKYE | Stock Option (Right to Buy) | Common Stock | $14.56 | March 1, 2034 | 35,000 | Acquired |
| Nov. 6, 2023 | SKYE | Stock Option (Right to Buy) | Common Stock | $3.50 | Aug. 25, 2033 | 14,110 | Acquired |
| Aug. 25, 2023 | SKYE | Stock Option (Right to Buy) | Common Stock | $0.01 | Aug. 25, 2033 | 1,472,692 | Acquired |
| Jan. 5, 2023 | SKYE | Stock Option (Right to Buy) | Common Stock | $0.02 | Jan. 5, 2033 | 250,000 | Acquired |
| Sept. 14, 2021 | SKYE | Director Stock Option (Right to Buy) | Common Stock | $0.12 | Sept. 14, 2031 | 150,000 | Acquired |
| Aug. 7, 2020 | SKYE | Director Option Grant (Right to Buy) | Common Stock | $0.04 | Aug. 7, 2030 | 250,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).